Nautilus Biotechnology (NAUT) Cash from Operations (2020 - 2026)
Nautilus Biotechnology has reported Cash from Operations over the past 7 years, most recently at 13100000.0 for Q1 2026.
- Quarterly results put Cash from Operations at 13100000.0 for Q1 2026, up 6.01% from a year ago — trailing twelve months through Mar 2026 was 49859000.0 (up 12.24% YoY), and the annual figure for FY2025 was 50696000.0, up 14.29%.
- Cash from Operations reached 13100000.0 in Q1 2026 per NAUT's latest filing, down from 12375000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 9565000.0 in Q3 2022 and bottomed at 16266000.0 in Q1 2024.
- Median Cash from Operations over the past 5 years was 13113000.0 (2024), compared with a mean of 12968117.65.
- Peak annual rise in Cash from Operations hit 32.53% in 2022, while the deepest fall reached 97.27% in 2022.
- Over 5 years, Cash from Operations stood at 10377000.0 in 2022, then crashed by 33.95% to 13900000.0 in 2023, then dropped by 2.94% to 14309000.0 in 2024, then increased by 13.52% to 12375000.0 in 2025, then fell by 5.86% to 13100000.0 in 2026.
- Business Quant data shows Cash from Operations for NAUT at 13100000.0 in Q1 2026, 12375000.0 in Q4 2025, and 11034000.0 in Q3 2025.